Cancer Pathology Data Sharing
2.0.0-ballot - STU 2 Ballot
Cancer Pathology Data Sharing
2.0.0-ballot - STU 2 Ballot
This page is part of the Sharing eCC Data from Pathology Labs to EHR (v2.0.0-ballot: STU 2 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This version is a pre-release. The current official version is 1.0.1. For a full list of available versions, see the Directory of published versions
| Page standards status: Trial-use |
{
"resourceType" : "CodeSystem",
"id" : "cap-ecc-codesystem",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cap-ecc-codesystem</b></p><a name=\"cap-ecc-codesystem\"> </a><a name=\"hccap-ecc-codesystem\"> </a><a name=\"cap-ecc-codesystem-en-US\"> </a><p>This case-insensitive code system <code>http://hl7.org/fhir/us/cancer-reporting/CodeSystem/cap-ecc-codesystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">31357.100004300<a name=\"cap-ecc-codesystem-31357.46100004300\"> </a></td><td>Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))</td></tr><tr><td style=\"white-space:nowrap\">30148.100004300<a name=\"cap-ecc-codesystem-30148.46100004300\"> </a></td><td>Tumor Size (Note E)</td></tr><tr><td style=\"white-space:nowrap\">51180.100004300<a name=\"cap-ecc-codesystem-51180.46100004300\"> </a></td><td>Tumor Site (Note B)</td></tr><tr><td style=\"white-space:nowrap\">16448.100004300<a name=\"cap-ecc-codesystem-16448.46100004300\"> </a></td><td>Single focus of invasive carcinoma</td></tr><tr><td style=\"white-space:nowrap\">38392.100004300<a name=\"cap-ecc-codesystem-38392.46100004300\"> </a></td><td>Tumor Focality (Note F)</td></tr><tr><td style=\"white-space:nowrap\">16214.100004300<a name=\"cap-ecc-codesystem-16214.46100004300\"> </a></td><td>Specimen Laterality</td></tr><tr><td style=\"white-space:nowrap\">16215.100004300<a name=\"cap-ecc-codesystem-16215.46100004300\"> </a></td><td>Right</td></tr><tr><td style=\"white-space:nowrap\">52399.100004300<a name=\"cap-ecc-codesystem-52399.46100004300\"> </a></td><td>HER2 (by immunohistochemistry)</td></tr><tr><td style=\"white-space:nowrap\">36944.100004300<a name=\"cap-ecc-codesystem-36944.46100004300\"> </a></td><td>HER2 (by immunohistochemistry)</td></tr><tr><td style=\"white-space:nowrap\">43789.100004300<a name=\"cap-ecc-codesystem-43789.46100004300\"> </a></td><td>Breast Biomarker Testing Performed on Previous Biopsy</td></tr><tr><td style=\"white-space:nowrap\">41776.100004300<a name=\"cap-ecc-codesystem-41776.46100004300\"> </a></td><td>Estrogen Receptor (ER)</td></tr><tr><td style=\"white-space:nowrap\">45138.100004300<a name=\"cap-ecc-codesystem-45138.46100004300\"> </a></td><td>Estrogen Receptor (ER) Status</td></tr><tr><td style=\"white-space:nowrap\">53472.100004300<a name=\"cap-ecc-codesystem-53472.46100004300\"> </a></td><td>Cannot be determined (indeterminate)</td></tr><tr><td style=\"white-space:nowrap\">16280.100004300<a name=\"cap-ecc-codesystem-16280.46100004300\"> </a></td><td>Invasive carcinoma of no special type (ductal)</td></tr><tr><td style=\"white-space:nowrap\">41794.100004300<a name=\"cap-ecc-codesystem-41794.46100004300\"> </a></td><td>Histologic Type (Note C)</td></tr><tr><td style=\"white-space:nowrap\">16182.100004300<a name=\"cap-ecc-codesystem-16182.46100004300\"> </a></td><td>SPECIMEN</td></tr><tr><td style=\"white-space:nowrap\">17834.100004300<a name=\"cap-ecc-codesystem-17834.46100004300\"> </a></td><td>SPECIAL STUDIES</td></tr><tr><td style=\"white-space:nowrap\">39858.100004300<a name=\"cap-ecc-codesystem-39858.46100004300\"> </a></td><td>Regional Lymph Nodes</td></tr><tr><td style=\"white-space:nowrap\">16697.100004300<a name=\"cap-ecc-codesystem-16697.46100004300\"> </a></td><td>REGIONAL LYMPH NODES (Note M)</td></tr><tr><td style=\"white-space:nowrap\">16717.100004300<a name=\"cap-ecc-codesystem-16717.46100004300\"> </a></td><td>PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)</td></tr><tr><td style=\"white-space:nowrap\">16567.100004300<a name=\"cap-ecc-codesystem-16567.46100004300\"> </a></td><td>MARGINS (Note L)</td></tr><tr><td style=\"white-space:nowrap\">868263.100004300<a name=\"cap-ecc-codesystem-868263.46100004300\"> </a></td><td>Lymph Nodes</td></tr><tr><td style=\"white-space:nowrap\">352333.100004300<a name=\"cap-ecc-codesystem-352333.46100004300\"> </a></td><td>DISTANT METASTASIS</td></tr><tr><td style=\"white-space:nowrap\">381061.100004300<a name=\"cap-ecc-codesystem-381061.46100004300\"> </a></td><td>COMMENTS</td></tr><tr><td style=\"white-space:nowrap\">16782.100004300<a name=\"cap-ecc-codesystem-16782.46100004300\"> </a></td><td>ADDITIONAL FINDINGS (Note N)</td></tr><tr><td style=\"white-space:nowrap\">351607.100004300<a name=\"cap-ecc-codesystem-351607.46100004300\"> </a></td><td>?Number of Sentinel Nodes Examined (if applicable)</td></tr><tr><td style=\"white-space:nowrap\">351606.100004300<a name=\"cap-ecc-codesystem-351606.46100004300\"> </a></td><td>Exact number (specify)</td></tr><tr><td style=\"white-space:nowrap\">351601.100004300<a name=\"cap-ecc-codesystem-351601.46100004300\"> </a></td><td>Exact number (specify)</td></tr><tr><td style=\"white-space:nowrap\">351602.100004300<a name=\"cap-ecc-codesystem-351602.46100004300\"> </a></td><td>Total Number of Lymph Nodes Examined (sentinel and non-sentinel)</td></tr><tr><td style=\"white-space:nowrap\">374353.100004300<a name=\"cap-ecc-codesystem-374353.46100004300\"> </a></td><td>Regional lymph nodes present</td></tr><tr><td style=\"white-space:nowrap\">351589.100004300<a name=\"cap-ecc-codesystem-351589.46100004300\"> </a></td><td>Regional Lymph Node Status</td></tr><tr><td style=\"white-space:nowrap\">16736.100004300<a name=\"cap-ecc-codesystem-16736.46100004300\"> </a></td><td>pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension</td></tr><tr><td style=\"white-space:nowrap\">327740.100004300<a name=\"cap-ecc-codesystem-327740.46100004300\"> </a></td><td>pT Category</td></tr><tr><td style=\"white-space:nowrap\">763178.100004300<a name=\"cap-ecc-codesystem-763178.46100004300\"> </a></td><td>pN Category</td></tr><tr><td style=\"white-space:nowrap\">38649.100004300<a name=\"cap-ecc-codesystem-38649.46100004300\"> </a></td><td>pN0: No regional lymph node metastasis identified or ITCs only#</td></tr><tr><td style=\"white-space:nowrap\">58807.100004300<a name=\"cap-ecc-codesystem-58807.46100004300\"> </a></td><td>Procedure (Note A)</td></tr><tr><td style=\"white-space:nowrap\">40307.100004300<a name=\"cap-ecc-codesystem-40307.46100004300\"> </a></td><td>Excision (less than total mastectomy)</td></tr><tr><td style=\"white-space:nowrap\">38391.100004300<a name=\"cap-ecc-codesystem-38391.46100004300\"> </a></td><td>Overall Grade</td></tr><tr><td style=\"white-space:nowrap\">16390.100004300<a name=\"cap-ecc-codesystem-16390.46100004300\"> </a></td><td>Grade 1 (scores of 3, 4 or 5)</td></tr><tr><td style=\"white-space:nowrap\">380283.100004300<a name=\"cap-ecc-codesystem-380283.46100004300\"> </a></td><td>Nottingham Score</td></tr><tr><td style=\"white-space:nowrap\">38125.100004300<a name=\"cap-ecc-codesystem-38125.46100004300\"> </a></td><td>Nuclear Pleomorphism</td></tr><tr><td style=\"white-space:nowrap\">16355.100004300<a name=\"cap-ecc-codesystem-16355.46100004300\"> </a></td><td>Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)</td></tr><tr><td style=\"white-space:nowrap\">16383.100004300<a name=\"cap-ecc-codesystem-16383.46100004300\"> </a></td><td>Score 1</td></tr><tr><td style=\"white-space:nowrap\">38390.100004300<a name=\"cap-ecc-codesystem-38390.46100004300\"> </a></td><td>Mitotic Rate</td></tr><tr><td style=\"white-space:nowrap\">351503.100004300<a name=\"cap-ecc-codesystem-351503.46100004300\"> </a></td><td>?Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)</td></tr><tr><td style=\"white-space:nowrap\">351504.100004300<a name=\"cap-ecc-codesystem-351504.46100004300\"> </a></td><td>All margins negative for invasive carcinoma</td></tr><tr><td style=\"white-space:nowrap\">351501.100004300<a name=\"cap-ecc-codesystem-351501.46100004300\"> </a></td><td>Lateral</td></tr><tr><td style=\"white-space:nowrap\">16348.100004300<a name=\"cap-ecc-codesystem-16348.46100004300\"> </a></td><td>Score 2 (10 to 75% of tumor area forming glandular / tubular structures)</td></tr><tr><td style=\"white-space:nowrap\">38124.100004300<a name=\"cap-ecc-codesystem-38124.46100004300\"> </a></td><td>Glandular (Acinar) / Tubular Differentiation</td></tr><tr><td style=\"white-space:nowrap\">44040.100004300<a name=\"cap-ecc-codesystem-44040.46100004300\"> </a></td><td>Ductal Carcinoma In Situ (DCIS) (Note G)</td></tr><tr><td style=\"white-space:nowrap\">16306.100004300<a name=\"cap-ecc-codesystem-16306.46100004300\"> </a></td><td>Not identified</td></tr><tr><td style=\"white-space:nowrap\">352343.100004300<a name=\"cap-ecc-codesystem-352343.46100004300\"> </a></td><td>?Not applicable</td></tr><tr><td style=\"white-space:nowrap\">42418.100004300<a name=\"cap-ecc-codesystem-42418.46100004300\"> </a></td><td>Clock position</td></tr><tr><td style=\"white-space:nowrap\">352334.100004300<a name=\"cap-ecc-codesystem-352334.46100004300\"> </a></td><td>?Distant Site(s) Involved, if applicable</td></tr><tr><td style=\"white-space:nowrap\">16259.100004300<a name=\"cap-ecc-codesystem-16259.46100004300\"> </a></td><td>Specify Clock Position</td></tr><tr><td style=\"white-space:nowrap\">6643.100004300<a name=\"cap-ecc-codesystem-6643.46100004300\"> </a></td><td>8 o'clock</td></tr><tr><td style=\"white-space:nowrap\">16783.100004300<a name=\"cap-ecc-codesystem-16783.46100004300\"> </a></td><td>Additional Findings (specify)</td></tr><tr><td style=\"white-space:nowrap\">31359.100004300<a name=\"cap-ecc-codesystem-31359.46100004300\"> </a></td><td>Additional Dimension in Millimeters (mm)</td></tr><tr><td style=\"white-space:nowrap\">Breast.Invasive.Res.189_4.009.021.REL_sdcFDF<a name=\"cap-ecc-codesystem-Breast.46Invasive.46Res.46189_4.46009.46021.46REL_sdcFDF\"> </a></td><td>INVASIVE CARCINOMA OF THE BREAST: Resection</td></tr><tr><td style=\"white-space:nowrap\">16249.100004300<a name=\"cap-ecc-codesystem-16249.46100004300\"> </a></td><td>TUMOR</td></tr><tr><td style=\"white-space:nowrap\">16403.100004300<a name=\"cap-ecc-codesystem-16403.46100004300\"> </a></td><td>Tumor Extent (Note H)</td></tr><tr><td style=\"white-space:nowrap\">868258.100004300<a name=\"cap-ecc-codesystem-868258.46100004300\"> </a></td><td>Primary Tumor Bed</td></tr><tr><td style=\"white-space:nowrap\">868272.100004300<a name=\"cap-ecc-codesystem-868272.46100004300\"> </a></td><td>RCB Calculations</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "oo"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/cancer-reporting/ImplementationGuide/hl7.fhir.us.cancer-reporting"
}
]
}
}
],
"url" : "http://hl7.org/fhir/us/cancer-reporting/CodeSystem/cap-ecc-codesystem",
"version" : "2.0.0-ballot",
"name" : "CAPeCCCodeSystem",
"title" : "CAP eCC CodeSystem",
"status" : "active",
"experimental" : false,
"date" : "2025-03-31T19:51:27+00:00",
"publisher" : "HL7 International / Orders and Observations and College of American Pathologists",
"contact" : [
{
"name" : "HL7 International / Orders and Observations and College of American Pathologists",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/orders"
},
{
"system" : "email",
"value" : "ord@lists.HL7.org"
}
]
}
],
"description" : "A CodeSystem for CAP eCC codes",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"caseSensitive" : false,
"content" : "complete",
"count" : 63,
"concept" : [
{
"code" : "31357.100004300",
"display" : "Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))"
},
{
"code" : "30148.100004300",
"display" : "Tumor Size (Note E)"
},
{
"code" : "51180.100004300",
"display" : "Tumor Site (Note B)"
},
{
"code" : "16448.100004300",
"display" : "Single focus of invasive carcinoma"
},
{
"code" : "38392.100004300",
"display" : "Tumor Focality (Note F)"
},
{
"code" : "16214.100004300",
"display" : "Specimen Laterality"
},
{
"code" : "16215.100004300",
"display" : "Right"
},
{
"code" : "52399.100004300",
"display" : "HER2 (by immunohistochemistry)"
},
{
"code" : "36944.100004300",
"display" : "HER2 (by immunohistochemistry)"
},
{
"code" : "43789.100004300",
"display" : "Breast Biomarker Testing Performed on Previous Biopsy"
},
{
"code" : "41776.100004300",
"display" : "Estrogen Receptor (ER)"
},
{
"code" : "45138.100004300",
"display" : "Estrogen Receptor (ER) Status"
},
{
"code" : "53472.100004300",
"display" : "Cannot be determined (indeterminate)"
},
{
"code" : "16280.100004300",
"display" : "Invasive carcinoma of no special type (ductal)"
},
{
"code" : "41794.100004300",
"display" : "Histologic Type (Note C)"
},
{
"code" : "16182.100004300",
"display" : "SPECIMEN"
},
{
"code" : "17834.100004300",
"display" : "SPECIAL STUDIES"
},
{
"code" : "39858.100004300",
"display" : "Regional Lymph Nodes"
},
{
"code" : "16697.100004300",
"display" : "REGIONAL LYMPH NODES (Note M)"
},
{
"code" : "16717.100004300",
"display" : "PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)"
},
{
"code" : "16567.100004300",
"display" : "MARGINS (Note L)"
},
{
"code" : "868263.100004300",
"display" : "Lymph Nodes"
},
{
"code" : "352333.100004300",
"display" : "DISTANT METASTASIS"
},
{
"code" : "381061.100004300",
"display" : "COMMENTS"
},
{
"code" : "16782.100004300",
"display" : "ADDITIONAL FINDINGS (Note N)"
},
{
"code" : "351607.100004300",
"display" : "?Number of Sentinel Nodes Examined (if applicable)"
},
{
"code" : "351606.100004300",
"display" : "Exact number (specify)"
},
{
"code" : "351601.100004300",
"display" : "Exact number (specify)"
},
{
"code" : "351602.100004300",
"display" : "Total Number of Lymph Nodes Examined (sentinel and non-sentinel)"
},
{
"code" : "374353.100004300",
"display" : "Regional lymph nodes present"
},
{
"code" : "351589.100004300",
"display" : "Regional Lymph Node Status"
},
{
"code" : "16736.100004300",
"display" : "pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension"
},
{
"code" : "327740.100004300",
"display" : "pT Category"
},
{
"code" : "763178.100004300",
"display" : "pN Category"
},
{
"code" : "38649.100004300",
"display" : "pN0: No regional lymph node metastasis identified or ITCs only#"
},
{
"code" : "58807.100004300",
"display" : "Procedure (Note A)"
},
{
"code" : "40307.100004300",
"display" : "Excision (less than total mastectomy)"
},
{
"code" : "38391.100004300",
"display" : "Overall Grade"
},
{
"code" : "16390.100004300",
"display" : "Grade 1 (scores of 3, 4 or 5)"
},
{
"code" : "380283.100004300",
"display" : "Nottingham Score"
},
{
"code" : "38125.100004300",
"display" : "Nuclear Pleomorphism"
},
{
"code" : "16355.100004300",
"display" : "Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)"
},
{
"code" : "16383.100004300",
"display" : "Score 1"
},
{
"code" : "38390.100004300",
"display" : "Mitotic Rate"
},
{
"code" : "351503.100004300",
"display" : "?Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)"
},
{
"code" : "351504.100004300",
"display" : "All margins negative for invasive carcinoma"
},
{
"code" : "351501.100004300",
"display" : "Lateral"
},
{
"code" : "16348.100004300",
"display" : "Score 2 (10 to 75% of tumor area forming glandular / tubular structures)"
},
{
"code" : "38124.100004300",
"display" : "Glandular (Acinar) / Tubular Differentiation"
},
{
"code" : "44040.100004300",
"display" : "Ductal Carcinoma In Situ (DCIS) (Note G)"
},
{
"code" : "16306.100004300",
"display" : "Not identified"
},
{
"code" : "352343.100004300",
"display" : "?Not applicable"
},
{
"code" : "42418.100004300",
"display" : "Clock position"
},
{
"code" : "352334.100004300",
"display" : "?Distant Site(s) Involved, if applicable"
},
{
"code" : "16259.100004300",
"display" : "Specify Clock Position"
},
{
"code" : "6643.100004300",
"display" : "8 o'clock"
},
{
"code" : "16783.100004300",
"display" : "Additional Findings (specify)"
},
{
"code" : "31359.100004300",
"display" : "Additional Dimension in Millimeters (mm)"
},
{
"code" : "Breast.Invasive.Res.189_4.009.021.REL_sdcFDF",
"display" : "INVASIVE CARCINOMA OF THE BREAST: Resection"
},
{
"code" : "16249.100004300",
"display" : "TUMOR"
},
{
"code" : "16403.100004300",
"display" : "Tumor Extent (Note H)"
},
{
"code" : "868258.100004300",
"display" : "Primary Tumor Bed"
},
{
"code" : "868272.100004300",
"display" : "RCB Calculations"
}
]
}
IG © 2025+ HL7 International / Orders and Observations and College of American Pathologists. Package hl7.fhir.us.cancer-reporting#2.0.0-ballot based on FHIR 4.0.1. Generated 2025-03-31
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change